UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PE and PET oligomers' interplay with membrane bilayers

Scientific reports, 2022-02, Vol.12 (1), p.2234-8, Article 2234

2022

Volltextzugriff (PDF)

N-Acylethanolamines Bind to SIRT6

Chembiochem : a European journal of chemical biology, 2016-01, Vol.17 (1), p.77-81

2016

Volltextzugriff (PDF)

Dynamics behavior of PE and PET oligomers in lipid bilayer simulations

Microplastics and nanoplastics, 2023-12, Vol.3 (1), p.27-13, Article 27

2023

Volltextzugriff (PDF)

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

The Journal of clinical investigation, 2018-08, Vol.128 (8), p.3341-3355

2018

Volltextzugriff (PDF)

Natural polyphenols as sirtuin 6 modulators

Scientific reports, 2018-03, Vol.8 (1), p.4163-11, Article 4163

2018

Volltextzugriff (PDF)

Sirtuin functions and modulation: from chemistry to the clinic

Clinical epigenetics, 2016-05, Vol.8 (61), p.61-61, Article 61

2016

Volltextzugriff (PDF)

Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2‑Selective Inhibitors

Journal of medicinal chemistry, 2012-08, Vol.55 (16), p.7104-7113

2012

Volltextzugriff (PDF)

Quercetin based derivatives as sirtuin inhibitors

Biomedicine & pharmacotherapy, 2019-03, Vol.111, p.1326-1333

2019

Volltextzugriff (PDF)

Potent mechanism-based sirtuin-2-selective inhibition by an in situ -generated occupant of the substrate-binding site, "selectivity pocket" and NAD + -binding site

Chemical science (Cambridge), 2017-09, Vol.8 (9), p.6400-6408

2017

Volltextzugriff (PDF)

Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines

Biomedicine & pharmacotherapy, 2022-03, Vol.147, p.112652-112652, Article 112652

2022

Volltextzugriff (PDF)

Studying SIRT6 regulation using H3K56 based substrate and small molecules

European journal of pharmaceutical sciences, 2014-10, Vol.63, p.71-76

2014

Volltextzugriff (PDF)

SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (1), p.127

2023

Volltextzugriff (PDF)

Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities

Biomedicine & pharmacotherapy, 2020-11, Vol.131, p.110701-110701, Article 110701

2020

Volltextzugriff (PDF)

Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells

Biomedicine & pharmacotherapy, 2021-06, Vol.138, p.111452-111452, Article 111452

2021

Volltextzugriff (PDF)

Quantitative Insight into the Design of Compounds Recognized by the L-Type Amino Acid Transporter 1 (LAT1)

ChemMedChem, 2014-12, Vol.9 (12), p.2699-2707

2014

Volltextzugriff (PDF)

BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses

Chembiochem : a European journal of chemical biology, 2015-09, Vol.16 (14), p.1997-2001

2015

Volltextzugriff (PDF)

Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells

Journal of medicinal chemistry, 2012-12, Vol.55 (24), p.10937-10947

2012

Volltextzugriff (PDF)

Virtual screening approach of sirtuin inhibitors results in two new scaffolds

European journal of pharmaceutical sciences, 2015-08, Vol.76, p.27-32

2015

Volltextzugriff (PDF)

Structure–activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion

European journal of pharmaceutical sciences, 2013-02, Vol.48 (3), p.523-531

2013

Volltextzugriff (PDF)

The Effect of Ligand-Based Tautomer and Protomer Prediction on Structure-Based Virtual Screening

Journal of chemical information and modeling, 2009-12, Vol.49 (12), p.2742-2748

2009

Volltextzugriff (PDF)

2‑Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors

ACS medicinal chemistry letters, 2021-10, Vol.12 (10), p.1578-1584

2021

Volltextzugriff (PDF)

Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2

European journal of medicinal chemistry, 2015-03, Vol.92, p.766-775

2015

Volltextzugriff (PDF)

Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors

ACS medicinal chemistry letters, 2019-12, Vol.10 (12), p.1635-1640

2019

Volltextzugriff (PDF)

Virtual Screening of Small Drug-Like Compounds Stimulating the Enzymatic Activity of Kallikrein-Related Peptidase 3 (KLK3)

ChemMedChem, 2016-09, Vol.11 (18), p.2043-2049

2016

Volltextzugriff (PDF)

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 Inhibitors

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4377-4380

2008

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(79)
Buchkapitel
(1)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(57)
Pharmacology & Pharmacy
(47)
Humans
(40)
Chemistry, Medicinal
(34)
Models, Molecular
(18)
Structure-Activity Relationship
(17)
Biochemistry & Molecular Biology
(13)
Chemistry
(13)
Molecular Structure
(12)
Physical Sciences
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Sirtuins - Metabolism
(11)
Animals
(10)
Binding Sites
(10)
Cancer
(10)
Molecular Docking Simulation
(10)
Pharmacology. Drug Treatments
(10)
Sirtuins - Antagonists & Inhibitors
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PE and PET oligomers' interplay with membrane bilayers

N-Acylethanolamines Bind to SIRT6

Dynamics behavior of PE and PET oligomers in lipid bilayer simulations

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

Natural polyphenols as sirtuin 6 modulators

Sirtuin functions and modulation: from chemistry to the clinic

Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2‑Selective Inhibitors

Quercetin based derivatives as sirtuin inhibitors

Potent mechanism-based sirtuin-2-selective inhibition by an in situ -generated occupant of the substrate-binding site, "selectivity pocket" and NAD + -binding site

Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines

Studying SIRT6 regulation using H3K56 based substrate and small molecules

SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors

Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities

Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells

Quantitative Insight into the Design of Compounds Recognized by the L-Type Amino Acid Transporter 1 (LAT1)

BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses

Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells

Virtual screening approach of sirtuin inhibitors results in two new scaffolds

Structure–activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion

The Effect of Ligand-Based Tautomer and Protomer Prediction on Structure-Based Virtual Screening

2‑Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors

Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2

Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors

Virtual Screening of Small Drug-Like Compounds Stimulating the Enzymatic Activity of Kallikrein-Related Peptidase 3 (KLK3)

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 Inhibitors

Suchergebnisse filtern